Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Change in Net Loans (2018 - 2023)

Elite Health Systems' Change in Net Loans history spans 6 years, with the latest figure at -$25000.0 for Q4 2023.

  • Quarterly results put Change in Net Loans at -$25000.0 for Q4 2023, up 84.76% from a year ago — trailing twelve months through Dec 2024 was -$25000.0 (up 63.77% YoY), and the annual figure for FY2023 was -$69000.0, up 74.82%.
  • Change in Net Loans for Q4 2023 was -$25000.0 at Elite Health Systems, up from -$44000.0 in the prior quarter.
  • In the past five years, Change in Net Loans ranged from a high of -$3000.0 in Q4 2019 to a low of -$351000.0 in Q2 2019.
  • The 5-year median for Change in Net Loans is -$34500.0 (2023), against an average of -$81166.7.
  • The sharpest move saw Change in Net Loans crashed 1390.91% in 2022, then surged 84.76% in 2023.
  • Year by year, Change in Net Loans stood at -$3000.0 in 2019, then tumbled by 66.67% to -$5000.0 in 2020, then plummeted by 120.0% to -$11000.0 in 2021, then crashed by 1390.91% to -$164000.0 in 2022, then surged by 84.76% to -$25000.0 in 2023.
  • According to Business Quant data, Change in Net Loans over the past three periods came in at -$25000.0, -$44000.0, and -$164000.0 for Q4 2023, Q2 2023, and Q4 2022 respectively.